1-12 of 12
Thomas A. Waldmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

Wei Chen, Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2082–2093.
https://doi.org/10.1158/1078-0432.CCR-21-0496
Published: 13 May 2022
View article titled, IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors
Open the PDF for IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors in another window
Includes: Supplementary data
Journal Articles

A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models

Wei Wei, Yuquan Lin, Zhihui Song, Wenming Xiao, Liqi Chen, Jiejing Yin, Yan Zhou, Stefan K. Barta, Michael Petrus, Thomas A. Waldmann, Yibin Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15): 4093–4106.
https://doi.org/10.1158/1078-0432.CCR-19-4137
Published: 03 August 2020
View article titled, A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models
Open the PDF for A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models in another window
Includes: Supplementary data
Journal Articles

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi-Chia Richard Lee, Milos D. Miljkovic, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4945–4954.
https://doi.org/10.1158/1078-0432.CCR-18-3468
Published: 15 August 2019
View article titled, IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Open the PDF for IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion in another window
Includes: Supplementary data
Journal Articles

A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors

Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish R. Patel, Holbrook E.K. Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary L. Disis, Judith C. Kaiser, Martin A. Cheever, Howard Streicher, Steven P. Creekmore, Thomas A. Waldmann, Kevin C. Conlon
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (7): 1525–1535.
https://doi.org/10.1158/1078-0432.CCR-17-2451
Published: 02 April 2018
View article titled, A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Open the PDF for A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors in another window
Journal Articles

Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma

Kamal Sharma, John E. Janik, Deirdre O'Mahony, Donn Stewart, Stefania Pittaluga, Maryalice Stetler-Stevenson, Elaine S. Jaffe, Mark Raffeld, Thomas A. Fleisher, Cathryn C. Lee, Seth M. Steinberg, Thomas A. Waldmann, John C. Morris
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 35–42.
https://doi.org/10.1158/1078-0432.CCR-16-1022
Published: 02 January 2017
View article titled, Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma
Open the PDF for Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma in another window
Includes: Supplementary data
Journal Articles

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity

Robert J. Kreitman, Maryalice Stetler-Stevenson, Elaine S. Jaffe, Kevin C. Conlon, Seth M. Steinberg, Wyndham Wilson, Thomas A. Waldmann, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 310–318.
https://doi.org/10.1158/1078-0432.CCR-15-1412
Published: 14 January 2016
View article titled, Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity
Open the PDF for Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity in another window
Journal Articles

Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model

Ping Yu, Jason C. Steel, Meili Zhang, John C. Morris, Thomas A. Waldmann
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (24): 6019–6028.
https://doi.org/10.1158/1078-0432.CCR-10-1966
Published: 16 December 2010
View article titled, Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
Open the PDF for Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model in another window
Includes: Supplementary data
Journal Articles

EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

Deirdre O'Mahony, John C. Morris, Maryalice Stetler-Stevenson, Helen Matthews, Margaret R. Brown, Thomas Fleisher, Stefania Pittaluga, Mark Raffeld, Paul S. Albert, Dirk Reitsma, Karen Kaucic, Luz Hammershaimb, Thomas A. Waldmann, John E. Janik
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2514–2522.
https://doi.org/10.1158/1078-0432.CCR-08-1254
Published: 01 April 2009
View article titled, EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies
Open the PDF for EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies in another window
Includes: Supplementary data
Journal Articles

Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/neu Diabodies

Matthew K. Robinson, Calvin Shaller, Kayhan Garmestani, Paul S. Plascjak, Kathryn M. Hodge, Qing-An Yuan, James D. Marks, Thomas A. Waldmann, Martin W. Brechbiel, Gregory P. Adams
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 875–882.
https://doi.org/10.1158/1078-0432.CCR-07-1250
Published: 01 February 2008
View article titled, Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/<em>neu</em> Diabodies
Open the PDF for Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/<em>neu</em> Diabodies in another window
Journal Articles

A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy

Deirdre O'Mahony, John C. Morris, Cate Quinn, Wendy Gao, Wyndham H. Wilson, Barry Gause, Stefania Pittaluga, Sattva Neelapu, Margaret Brown, Thomas A. Fleisher, James L. Gulley, Jeffrey Schlom, Robert Nussenblatt, Paul Albert, Thomas A. Davis, Israel Lowy, Mike Petrus, Thomas A. Waldmann, John E. Janik
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 958–964.
https://doi.org/10.1158/1078-0432.CCR-06-1974
Published: 08 February 2007
View article titled, A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy
Open the PDF for A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy in another window
Journal Articles

Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation

Hisataka Kobayashi, Koen Reijnders, Sean English, Alexander T. Yordanov, Diane E. Milenic, Anastasia L. Sowers, Deborah Citrin, Murali C. Krishna, Thomas A. Waldmann, James B. Mitchell, Martin W. Brechbiel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7712–7720.
https://doi.org/10.1158/1078-0432.CCR-04-1175
Published: 29 November 2004
View article titled, Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation
Open the PDF for Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation in another window
Journal Articles

Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane- N , N ′, N ″, N ‴-Tetraacetic Acid-Biotin

Zhengsheng Yao, Meili Zhang, Kayhan Garmestani, Donald B. Axworthy, Robert W. Mallett, Alan R. Fritzberg, Lou J. Theodore, Paul S. Plascjak, William C. Eckelman, Thomas A. Waldmann, Ira Pastan, Chang H. Paik, Martin W. Brechbiel, Jorge A. Carrasquillo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (9): 3137–3146.
https://doi.org/10.1158/1078-0432.CCR-03-0171
Published: 06 May 2004
View article titled, Pretargeted α Emitting Radioimmunotherapy Using <sup>213</sup>Bi 1,4,7,10-Tetraazacyclododecane- <em>N</em> , <em>N</em> ′, <em>N</em> ″, <em>N</em> ‴-Tetraacetic Acid-Biotin
Open the PDF for Pretargeted α Emitting Radioimmunotherapy Using <sup>213</sup>Bi 1,4,7,10-Tetraazacyclododecane- <em>N</em> , <em>N</em> ′, <em>N</em> ″, <em>N</em> ‴-Tetraacetic Acid-Biotin in another window